Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

39.59
Delayed Data
As of May 23
 +0.95 / +2.46%
Today’s Change
33.60
Today|||52-Week Range
50.40
+3.77%
Year-to-Date
Mylan Stock Gains Following Barclays Upgrade
May 22 / TheStreet.com - Paid Partner Content
Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls
May 12 / Zacks.com - Paid Partner Content
John Paulson Sells VMware, Hewlett Packard, Several Other Holdings
May 19 / GuruFocus News - Paid Partner Content
SuperGroup's wholesale change translates into sales
May 11 / FT.com - Paid Partner Content
John Paulson Sells VMware, Hewlett Packard, Several Others
May 19 / GuruFocus News - Paid Partner Content
Company News for May 11, 2017
May 11 / Zacks.com - Paid Partner Content
Joel Greenblatt's Top 3 New Stocks for the 1st Quarter
May 17 / GuruFocus News - Paid Partner Content
Mylan (MYL) Beats on Q1 Earnings, Revenues Miss Estimates
May 10 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study
May 12 / Zacks.com - Paid Partner Content
Mylan (MYL) Tops on Q1 Earnings
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.64
Today’s open38.97
Day’s range38.79 - 40.10
Volume7,414,662
Average volume (3 months)5,656,040
Market cap$20.3B
Dividend yield--
Data as of 4:00pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)+7.14%
Earnings growth (next 5 years)+8.20%
Revenue growth (last year)+17.44%
P/E ratio17.1
Price/Sales1.79
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-2.13-2.35%
ALXNAlexion Pharmaceutic...-10.78-9.34%
INCYIncyte Corp+1.73+1.29%
VRTXVertex Pharmaceutica...-2.35-1.98%
Data as of 4:14pm ET, 05/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts